Table of Contents

2019-2024 Global Psoriatic Arthritis (PsA) Treatment Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size 2014-2024
2.1.2 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region
2.2 Psoriatic Arthritis (PsA) Treatment Segment by Type
2.2.1 Nonsteriodal Anti-inflammatory Drugs
2.2.2 Disease Modifying Antirheumatic Drugs
2.2.3 Biologics
2.3 Psoriatic Arthritis (PsA) Treatment Market Size by Type
2.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2014-2019)
2.3.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (2014-2019)
2.4 Psoriatic Arthritis (PsA) Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Psoriatic Arthritis (PsA) Treatment Market Size by Application
2.5.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2014-2019)
2.5.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Application (2014-2019)

3 Global Psoriatic Arthritis (PsA) Treatment by Players
3.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Players
3.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Players (2017-2019)
3.1.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Players (2017-2019)
3.2 Global Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Psoriatic Arthritis (PsA) Treatment by Regions
4.1 Psoriatic Arthritis (PsA) Treatment Market Size by Regions
4.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size Growth
4.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size Growth
4.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth
4.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth

5 Americas
5.1 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Countries
5.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type
5.3 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Countries
6.2 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type
6.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Psoriatic Arthritis (PsA) Treatment by Countries
7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type
7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment by Countries
8.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type
8.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Psoriatic Arthritis (PsA) Treatment Market Forecast
10.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast (2019-2024)
10.2 Global Psoriatic Arthritis (PsA) Treatment Forecast by Regions
10.2.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Psoriatic Arthritis (PsA) Treatment Forecast by Type
10.8 Global Psoriatic Arthritis (PsA) Treatment Forecast by Application

11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Johnson & Johnson
11.2.1 Company Details
11.2.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Johnson & Johnson News
11.3 AbbVie
11.3.1 Company Details
11.3.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 AbbVie News
11.4 Novartis
11.4.1 Company Details
11.4.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Novartis News
11.5 UCB
11.5.1 Company Details
11.5.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 UCB News
11.6 Roche
11.6.1 Company Details
11.6.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Roche News
11.7 Bristol-Myers Squibb
11.7.1 Company Details
11.7.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Bristol-Myers Squibb News
11.8 Eli Lilly
11.8.1 Company Details
11.8.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Eli Lilly News
11.9 Amgen
11.9.1 Company Details
11.9.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Amgen News
11.10 AstraZeneca
11.10.1 Company Details
11.10.2 Psoriatic Arthritis (PsA) Treatment Product Offered
11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 AstraZeneca News
11.11 Celgene

12 Research Findings and Conclusion